These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 23135222)

  • 1. Towards microRNA-based therapeutics for diabetic nephropathy.
    Alvarez ML; DiStefano JK
    Diabetologia; 2013 Mar; 56(3):444-56. PubMed ID: 23135222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNAs in diabetic nephropathy: functions, biomarkers, and therapeutic targets.
    Kato M; Natarajan R
    Ann N Y Acad Sci; 2015 Sep; 1353(1):72-88. PubMed ID: 25877817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA: A new generation therapeutic target in diabetic nephropathy.
    Dewanjee S; Bhattacharjee N
    Biochem Pharmacol; 2018 Sep; 155():32-47. PubMed ID: 29940170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs in Diabetic Nephropathy: From Biomarkers to Therapy.
    Simpson K; Wonnacott A; Fraser DJ; Bowen T
    Curr Diab Rep; 2016 Mar; 16(3):35. PubMed ID: 26973290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging roles for miRNAs in the development, diagnosis, and treatment of diabetic nephropathy.
    DiStefano JK; Taila M; Alvarez ML
    Curr Diab Rep; 2013 Aug; 13(4):582-91. PubMed ID: 23666892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-184 is a downstream effector of albuminuria driving renal fibrosis in rats with diabetic nephropathy.
    Zanchi C; Macconi D; Trionfini P; Tomasoni S; Rottoli D; Locatelli M; Rudnicki M; Vandesompele J; Mestdagh P; Remuzzi G; Benigni A; Zoja C
    Diabetologia; 2017 Jun; 60(6):1114-1125. PubMed ID: 28364255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs in diabetic nephropathy: From molecular mechanisms to new therapeutic targets of treatment.
    Yarahmadi A; Shahrokhi SZ; Mostafavi-Pour Z; Azarpira N
    Biochem Pharmacol; 2021 Jul; 189():114301. PubMed ID: 33203517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-29c is a signature microRNA under high glucose conditions that targets Sprouty homolog 1, and its in vivo knockdown prevents progression of diabetic nephropathy.
    Long J; Wang Y; Wang W; Chang BH; Danesh FR
    J Biol Chem; 2011 Apr; 286(13):11837-48. PubMed ID: 21310958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of non-coding RNAs in diabetic nephropathy: potential applications as biomarkers for disease development and progression.
    Alvarez ML; Distefano JK
    Diabetes Res Clin Pract; 2013 Jan; 99(1):1-11. PubMed ID: 23102915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of biological targets of therapeutic intervention for diabetic nephropathy with bioinformatics approach.
    Wu T; Li Q; Wu T; Liu HY
    Exp Clin Endocrinol Diabetes; 2014 Nov; 122(10):587-91. PubMed ID: 25003364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miRNA signatures in diabetic retinopathy and nephropathy: delineating underlying mechanisms.
    Kaur P; Kotru S; Singh S; Munshi A
    J Physiol Biochem; 2022 Feb; 78(1):19-37. PubMed ID: 35098434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circ-AKT3 inhibits the accumulation of extracellular matrix of mesangial cells in diabetic nephropathy via modulating miR-296-3p/E-cadherin signals.
    Tang B; Li W; Ji TT; Li XY; Qu X; Feng L; Bai S
    J Cell Mol Med; 2020 Aug; 24(15):8779-8788. PubMed ID: 32597022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs in Podocyte Injury in Diabetic Nephropathy.
    Ishii H; Kaneko S; Yanai K; Aomatsu A; Hirai K; Ookawara S; Ishibashi K; Morishita Y
    Front Genet; 2020; 11():993. PubMed ID: 33193581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA TUG1 alleviates extracellular matrix accumulation via mediating microRNA-377 targeting of PPARγ in diabetic nephropathy.
    Duan LJ; Ding M; Hou LJ; Cui YT; Li CJ; Yu DM
    Biochem Biophys Res Commun; 2017 Mar; 484(3):598-604. PubMed ID: 28137588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of expression of different microRNAs on insulin secretion and diabetic nephropathy progression.
    Mafi A; Aghadavod E; Mirhosseini N; Mobini M; Asemi Z
    J Cell Physiol; 2018 Jan; 234(1):42-50. PubMed ID: 30078212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic miR-21 Silencing Ameliorates Diabetic Kidney Disease in Mice.
    Kölling M; Kaucsar T; Schauerte C; Hübner A; Dettling A; Park JK; Busch M; Wulff X; Meier M; Scherf K; Bukosza N; Szénási G; Godó M; Sharma A; Heuser M; Hamar P; Bang C; Haller H; Thum T; Lorenzen JM
    Mol Ther; 2017 Jan; 25(1):165-180. PubMed ID: 28129112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory cytokines in diabetic nephropathy.
    Donate-Correa J; Martín-Núñez E; Muros-de-Fuentes M; Mora-Fernández C; Navarro-González JF
    J Diabetes Res; 2015; 2015():948417. PubMed ID: 25785280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An insight of dysregulation of microRNAs in the pathogenesis of diabetic kidney disease.
    Zahari Sham SY; Abdullah M; Osman M; Seow HF
    Malays J Pathol; 2022 Aug; 44(2):187-201. PubMed ID: 36043582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging Roles for MicroRNAs in Diabetic Microvascular Disease: Novel Targets for Therapy.
    Zhang Y; Sun X; Icli B; Feinberg MW
    Endocr Rev; 2017 Apr; 38(2):145-168. PubMed ID: 28323921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA expression signatures and posttranscriptional regulation in diabetic nephropathy.
    Rudnicki M; Beckers A; Neuwirt H; Vandesompele J
    Nephrol Dial Transplant; 2015 Aug; 30 Suppl 4():iv35-42. PubMed ID: 26209736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.